Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 7.32 0.31 (4.42%) Market Cap: 972.32 Mil Enterprise Value: 932.14 Mil PE Ratio: 0 PB Ratio: 2.36 GF Score: 82/100

Maravai LifeSciences Holdings Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2021 / 06:10PM GMT
Release Date Price: $43.65 (+3.93%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good afternoon, everyone. I'm Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of welcoming the management team from Maravai LifeSciences with us this afternoon. We have Carl Hull, the Chief Executive Officer; and Kevin Herde, the Chief Financial Officer. Carl, Kevin, thanks so much for joining us. I appreciate you having -- you guys coming here.

Carl W. Hull
Maravai LifeSciences Holdings, Inc. - Co-Founder, Chairman & CEO

Hey, Matt, it's good to see you.

Questions & Answers

Matthew Carlisle Sykes;Carl W. Hull
Goldman Sachs Group, Inc., Research Division - Research Analyst;Maravai

Great. Maybe Carl, I'll turn it over to you first, just to kind of set the stage a little bit for us. Talk about some of the key highlights of Maravai and what investors really should be top of mind for them as they continue to look at Maravai.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot